Validation of a rodent model of Parkinson's disease: Evidence of a therapeutic window for oral sinemet

Brain Research Bulletin

Volumn 39, Issue 6, 1996, Pages 367-372

  Lindner, Mark D ^a   Plone, Melissa A ^a   Francis, Jonathan M ^a   Emerich, Dwaine F ^a  

^a CytoTherapeutics Inc   (United States)

Author keywords

6 OHDA; Animal model; Clinically relevant; Parkinsonian symptoms; Therapeutic window

Indexed keywords

CARBIDOPA; CARBIDOPA PLUS LEVODOPA; LEVODOPA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFECT; DYSKINESIA; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STEREOTYPY;

EID: 0029962329     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/0361-9230(96)00027-5     Document Type: Article

References (25)

1. Barker, R.; Dunnett, S.B. Ibotenic acid lesions of the striatum reduce drug-induced rotation in the 6-hydroxydopamine-lesioned rat. Exp. Brain Res. 101:365-374; 1994.
2. Creese, E.; Iversen, S. D. Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. Brain Res. 55:369-382; 1973.
3. Creese, I.; Burt, D. R.; Snyder, S. H. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science 197:596-598; 1977.
4. Creese, I.; Iversen, S. D. The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res. 83:419-436; 1975.
5. During, M. J.; Naegele, J. R.; Omalley, K. L.; Geller, A. I. Longterm behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266:1399-1403; 1994.
6. Emerich, D. F.; McDermott, P. E.; Krueger, P. M.; Frydel, B.; Sanberg, P. R.; Winn, S. R. Polymer-encapsulated PC12 cells promote recovery of motor function in aged rats. Exp. Neurol. 122:37-47; 1993.
7. Isacson, O. Behavioral effects and gene delivery in a rat model of Parkinson's disease. Science 269:856; 1995.
8. Langston, J. W.; Widner, H.; Goetz, C. G.; Brooks, D.; Fahn, S.; Freeman, T.; Watts, R. Core assessment program for intracerebral transplantations (CAPIT). Movement Disord. 7:2-13; 1992.
9. Lindner, M. D.; Winn, S. R.; Baetge, E. E.; Hammang, J. P.; Gentile, F. T.; Doherty, E.; McDermott, P. E.; Frydel, B.; Ullman, M. D.; Schallert, T.; Emerich, D. F. Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms. Exp. Neurol. 132:62 76; 1995.
10. Marshall, J. F. Somatosensory inattention after dopamine-depleting intracerebral 6-OHDA injections: Spontaneous recovery and pharmacological control. Brain Res. 177:311-324; 1979.
11. Marshall, J. F.; Gotthelf, T. Sensory inattention in rats with 6-hydroxydopamine-induced degeneration of ascending dopaminergic neurons: Apomorphine-induced reversal of deficits. Exp. Neurol. 65:398-411; 1979.
12. Marshall, J. F.; Ungerstedt, U. Striatal efferent fibers play a role in maintaining rotational behavior in the rat. Science 198:62-64; 1977.
13. Mouradian, M. M.; Heuser, I. J. E.; Baronti, F.; Fabbrini, G.; Juncos, J. L.; Chase, T. N. Pathogenesis of dyskinesias in Parkinson's disease. Ann. Neurol. 25:523-526; 1989.
14. Nikkhah, G.; Cunningham, M. G.; Mckay, R.; Bjorklund, A. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. II. Transplant-induced behavioral recovery. J. Neurosci. 15:3562-3570; 1995.
15. Nutt, J. G.; Carter, J. H.; Woodward, W. R. Long-duration response to levodopa. Neurology 45:1613-1616; 1995.
16. Olsson, M.; Nikkhah, G.; Bentlage, C.; Bjorklund, A. Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J. Neurosci. 15:3863-3875; 1995.
17. Reading, P. J.; Dunnett, S. B. 6-Hydroxydopamine lesions of nigrostriatal neurons as an animal model of Parkinson's disease. In: Woodruff, M. L.; Nonneman, A. J., eds. Toxin-induced models of neurological disorders. New York: Plenum Press; 1994:89-119.
18. Robinson, T. E.; Becker, J. B. The rotational behavior model: Asymmetry in the effects of unilateral 6-OHDA lesions of the substantia nigra in rats. Brain Res. 264:127-131; 1983.
19. Schallert, T. Models of neurological defects and defects in neurological models. Behav. Brain Sci. 18:68-69; 1995.
20. Schallert, T.; De Ryck, M.; Whishaw, I. Q.; Ramirez, V. D.; Teitelbaum, P. Excessive bracing reactions and their control by atropine and L-DOPA in an animal analog of parkinsonism. Exp. Neurol. 64:33-43; 1979.
21. Schallert, T.; Jones, T. A.; Norton, D. A clinically relevant unilateral rat model of parkinsonian akinesia. J. Neural Transplant. Plast. 3:332-333; 1992.
22. Schallert, T.; Upchurch, M.; Lobaugh, N.; Farrar, S. B.; Spirduso, W. W.; Gilliam, P.; Vaughn, D.; Wilcox, R. E. Tactile extinction: Distinguishing between sensorimotor and motor asymmetries in rats with unilateral nigrostriatal damage. Pharmacol. Biochem. Behav. 16:455-462; 1982.
23. Schallert, T.; Upchurch, M.; Wilcox, R. E.; Vaughn, D. M. Posture-independent sensorimotor analysis of inter-hemispheric receptor asymmetries in neostriatum. Pharmacol. Biochem. Behav. 18:753-759; 1983.
24. Schallert, T.; Whishaw, I. Q.; Ramirez, V. D.; Teitelbaum, P. Compulsive, abnormal walking caused by anticholinergics in akinetic, 6-hydroxydopamine-treated rats. Science 199:1461-1463; 1978.
25. Westlund, K. N.; Lu, Y.; Kadekaro, M.; Harmann, P.; Terrell, M. L.; Pizzo, D. P.; Hulsebosch, C. E.; Eisenberg, H. M.; Perezpolo, J. R. NGF-producing transfected 3T3 cells: Behavioral and histological assessment of transplants in nigral lesioned rats. J. Neurosci. Res. 41:367-373; 1995.